Biomarker may be able to track MS progress in the future

[MSUK]

A blood test could one day provide a fast, inexpensive way for multiple sclerosis patients to assess the effectiveness of their medications and track disease flares.

While the test is still years away from market, the new biotechnology may prove invaluable for people with multiple sclerosis (MS), a degenerative disease that affects the brain, spinal cord and optic nerve, causing disability, chronic fatigue and pain, among other symptoms. Currently, doctors and patients rely on MRIs, which are expensive and time-consuming, to evaluate the progress of MS and the effects of treatment........ Read More - http://www.ms-uk.org/index.cfm/biomarkersandmicroRNA